Jefferies Financial Group Inc. Sangamo Therapeutics, Inc Transaction History
Jefferies Financial Group Inc.
- $10.7 Billion
- Q1 2025
A detailed history of Jefferies Financial Group Inc. transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 53,600 shares of SGMO stock, worth $25,192. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,600
Previous 53,600
-0.0%
Holding current value
$25,192
Previous $54,000
35.19%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SGMO
# of Institutions
137Shares Held
51.2MCall Options Held
2.17MPut Options Held
1.82M-
Vanguard Group Inc Valley Forge, PA9.37MShares$4.41 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT6.87MShares$3.23 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.21 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.17MShares$1.49 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.28MShares$1.07 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $73.6M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...